当前位置： SCI文献检索 > CLINICAL DRUG INVESTIGATION期刊下所有文献 > Pharmacokinetics of Repeated Melatonin Drug Administrations Prior to and After Surgery.

Pharmacokinetics of Repeated Melatonin Drug Administrations Prior to and After Surgery.

Abstract：

BACKGROUND:Recent clinical studies have documented the analgesic, anti-inflammatory, antioxidative and anxiolytic effects of exogenous melatonin. The pharmacokinetic properties of melatonin have primarily been investigated in experimental studies. OBJECTIVE:The aim of this study was to estimate the pharmacokinetics of melatonin in patients undergoing surgery and general anesthesia. METHODS:The study was designed as a prospective, two-phase cohort study. Patients were candidates for subpectoral breast augmentation surgery, and surgical procedures were performed by a single surgeon. The perioperative treatment protocol was standardized between patients. During the study, each patient received two separate oral administrations of melatonin 10 mg. Melatonin was administered 60 min before surgery, and at 9:00 p.m. the evening after surgery. The pharmacokinetic variables absorption half-life (t ½ absorption), time to maximal plasma concentration (T max), maximal plasma concentration (C max), elimination half-life (t ½ elimination), and area under the melatonin plasma concentration-time curve from time zero to infinity (AUC ∞) were estimated for both study phases. RESULTS:Median (interquartile range) values of t ½ absorption and T max were significantly increased during the postoperative phase [10.8 (6.9-15.1) min; 90.0 (48.8-120.0) min] compared with perioperatively [9.5 (6.3-16.5) min; 30.0 (15.0-30.0) min] (p = 0.034; p = 0.002), respectively. C max values were significantly higher during surgery [5497.5 (2077.1-13,233.8) pg/ml] compared with postoperative values [2340.5 (1672.4-8871.4) pg/ml] (p = 0.005). Correspondingly, t ½ elimination was significantly extended during the postoperative phase [103.5 (57.8-237.8) min] compared with the perioperative phase [60.5 (47.8-83.6) min] (p = 0.015). AUC ∞ did not differ between the study phases (p > 0.05). CONCLUSIONS:These preliminary results indicate that postoperative melatonin dose should be augmented compared with preoperative administration if corresponding melatonin plasma levels are intended. Furthermore, postoperative administration times should be advanced compared with preoperative administration.

journal_name

Clin Drug Investig

journal_title

Clinical drug investigation

authors

Harpsøe NG,Andersen LP,Mielke LV,Jønsson B,Jenstrup MT,Gögenur I,Rosenberg J

doi

10.1007/s40261-016-0452-5

subject

Has Abstract

pub_date

2016-12-01 00:00:00

pages

1045-1050

issue

eissn

1173-2563

issn

1179-1918

pii

10.1007/s40261-016-0452-5

journal_volume

pub_type

杂志文章

在线工具

Pharmacokinetics of Repeated Melatonin Drug Administrations Prior to and After Surgery.